Xometry Reports Fourth Quarter and Full Year 2021 Results
[ Back ]   [ More News ]   [ Home ]
Xometry Reports Fourth Quarter and Full Year 2021 Results

ROCKVILLE, Md., March 17, 2022 (GLOBE NEWSWIRE) -- Xometry, Inc. (NASDAQ:XMTR), a leading global AI enabled digital manufacturing marketplace, today reported financial results for the fourth quarter ended December 31, 2021.

“In Q4 2021, Xometry continued to demonstrate strong growth across the board with accelerated demand from our larger customers. Our AI-driven platform gets smarter with each new data point leading to record gross margin,” said Randy Altschuler, Xometry’s CEO. “Although we are still in the early innings of the secular digitization of the manufacturing industry, Xometry has become the digital marketplace connecting buyers with sellers to unleash limitless product innovation.”

Fourth Quarter Financial Highlights

Fourth Quarter Business Highlights

Full Year Financial Highlights

Full Year Business Highlights

 


Financial Summary
(In thousands, except per share amounts)

  For the Three Months Ended December 31,     For the Year Ended December 31,    
  2021  2020  % Change  2021  2020  % Change 
  (unaudited)     (unaudited)       
Revenue $67,098  $37,980   77% $218,336  $141,406   54%
Gross profit  20,937   9,479   121%  57,141   33,286   72%
Net loss  (23,907)  (10,178)  135%  (61,381)  (31,085)  97%
EPS—basic and diluted  (0.53)  (1.34)  (60)%  (2.33)  (5.32)  (56)%
Adjusted EBITDA (Non-GAAP)(1)  (11,854)  (6,590)  80%  (39,757)  (23,498)  69%

(1)   These non-GAAP financial measures, and reasons why we believe these non-GAAP financial measures are useful, are described below and reconciled to their most directly comparable GAAP measures in the accompanying tables.

Key Operating Metrics(2):

  As of December 31, 
  2021  2020  %
Change
 
          
Active Buyers(3)  28,130   18,846   49%
Percentage of Revenue from Existing Accounts(3)  95%  95%  %
Accounts with Last Twelve-Months Spend of at Least $50,000(3)  701   389   80%
          

(2)   These key operating metrics are for Xometry (excluding any impacts from Thomas).
(3)   Amounts shown for Active Buyers and Accounts with Last Twelve-Months Spend of at Least $50,000 are as of December 31, 2021 and 2020, and Percentage of Revenue from Existing Accounts is presented for the quarters ended December 31, 2021 and 2020.

Subsequent to Fourth Quarter 2021

On February 4, 2022, the Company completed a private offering of $250 million aggregate principal amount of 1.00% Convertible Senior Notes due 2027 (the “Initial Notes”). The Initial Notes were issued pursuant to an indenture, dated February 4, 2022 (the “Indenture”), between the Company and U.S. Bank Trust Company, National Association, as trustee.

On February 10, 2022, the Company issued an additional $37.5 million aggregate principal amount of its 1.00% Convertible Senior Notes due 2027 (the “Additional Notes”) to the initial purchasers named in the purchase agreement. The issuance of the Additional Notes was pursuant to the initial purchasers’ exercise in full of their 13-day option to purchase Additional Notes granted in the original offering of $250 million aggregate principal amount of 1.00% Convertible Senior Notes due 2027. The proceeds from the Initial Notes and the Additional Notes (collectively referred to as the “Notes”) are expected to be used for working capital and other general corporate purposes. The Company may also use a portion of the net proceeds for acquisitions of, or strategic investments in, complementary businesses, products, services, or technologies. However, the Company does not have agreements or commitments with respect to any such acquisition or strategic investment at this time. The Notes are general unsecured obligations of the Company and will mature on February 1, 2027, unless earlier converted, redeemed or repurchased. Interest on the Notes will accrue at a rate of 1.00% per year from February 4, 2022 and will be payable semiannually in arrears on February 1 and August 1 of each year, beginning on August 1, 2022. In connection with the Notes offering, the Company received net cash proceeds of approximately $278.9 million, after deducting the initial purchasers discounts and commissions.

Financial Guidance and Outlook:

  Q1 2022  FY 2022 
  (in millions) 
  Low  High  Low  High 
Revenue $81.0  $82.0  $390.0  $400.0 
Adjusted EBITDA $(13.5) $(12.5) $(36.0) $(32.0)

Use of Non-GAAP Financial Measures

To supplement its consolidated financial statements, which are prepared and presented in accordance with generally accepted accounting principles in the United States of America (“GAAP”), Xometry, Inc. ("Xometry", the "Company", "we" or "our") uses Adjusted EBITDA, a non-GAAP financial measure, as described below. This non-GAAP financial measure is presented to enhance the user’s overall understanding of Xometry’s financial performance and should not be considered a substitute for, or superior to, the financial information prepared and presented in accordance with GAAP. The non-GAAP financial measure presented in this release, together with the GAAP financial results, are the primary measures used by the Company’s management and board of directors to understand and evaluate the Company’s financial performance and operating trends, including period-to-period comparisons, because they exclude certain expenses and gains that management believes are not indicative of the Company’s core operating results. Management also uses this measure to prepare and update the Company’s short and long term financial and operational plans, to evaluate investment decisions, and in its discussions with investors, commercial bankers, equity research analysts and other users of the Company’s financial statements. Accordingly, the Company believes that this non-GAAP financial measure provides useful information to investors and others in understanding and evaluating the Company’s operating results in the same manner as the Company’s management and in comparing operating results across periods and to those of Xometry’s peer companies. In addition, from time to time we may present adjusted information (for example, revenue growth) to exclude the impact of certain gains, losses or other changes that affect period-to-period comparability of our operating performance.

The use of non-GAAP financial measures has certain limitations because they do not reflect all items of income and expense, or cash flows, that affect the Company’s financial performance and operations. An additional limitation of non-GAAP financial measures is that they do not have standardized meanings, and therefore other companies, including peer companies, may use the same or similarly named measures but exclude or include different items or use different computations. Management compensates for these limitations by reconciling these non-GAAP financial measures to their most comparable GAAP financial measures in the tables captioned “Reconciliations of Non-GAAP Financial Measures” included at the end of this release. Investors and others are encouraged to review the Company’s financial information in its entirety and not rely on a single financial measure.

Key Terms for our Key Metrics and Non-GAAP Financial Measures

The Company defines Adjusted earnings before interest, taxes, depreciation and amortization (Adjusted EBITDA) as net income (loss) excluding interest income (expense), income tax (expense) benefit, and certain other non-cash or non-recurring items impacting net loss from time to time, principally comprised of depreciation and amortization, stock-based compensation, transaction costs, charitable contributions, income from unconsolidated joint venture and impairment charges. Management believes that the exclusion of certain expenses and gains in calculating Adjusted EBITDA provides a useful measure for period-to-period comparisons of the Company’s underlying core revenue and operating costs that is focused more closely on the current costs necessary to operate the Company’s businesses, and reflects its ongoing business in a manner that allows for meaningful analysis of trends. Management also believes that excluding certain non-cash charges can be useful because the amounts of such expenses is the result of long-term investment decisions made in previous periods rather than day-to-day operating decisions.

Active Buyers: The Company defines “buyers” as individuals who have placed an order to purchase on-demand parts or assemblies on our platform.  The Company defines Active Buyers as the number of buyers who have made at least one purchase on our marketplace during the last twelve months.

Percentage of Revenue from Existing Accounts: The Company defines “accounts” as an individual entity, such as a sole proprietor with a single buyer or corporate entities with multiple buyers, having purchased at least one part on our marketplace. The Company defines an existing account as an account where at least one buyer has made a purchase on our marketplace.

Accounts with Last Twelve-Month Spend of At Least $50,000: The Company defines Accounts with Last Twelve-Month Spend of At Least $50,000 as an account that has spent at least $50,000 on our marketplace in the most recent twelve-month period.

About Xometry

Xometry (XMTR) powers the industries of today and tomorrow by connecting the people with big ideas to the manufacturers who can bring them to life. Xometry’s digital marketplace gives manufacturers the critical resources they need to grow their business while also making it easy for buyers at Fortune 1000 companies to tap into global manufacturing capacity. Learn more at www.xometry.com or follow @xometry.

Conference Call

The Company will discuss its fourth quarter and full year 2021 financial results during a teleconference on 3/17/2022, at 5:00 PM ET/2:00 PM PT. The conference call can be accessed in the U.S. at 877-313-2061 or outside the U.S. at 470-495-9537 with the conference ID# 7397803. A live audio webcast of the call will also be available simultaneously at  investors.xometry.com. Following completion of the call, a recorded replay of the teleconference will be available in the investor relations section of Xometry's website. The earnings webcast presentation will be archived within the Investor Relations section of Xometry's website.

Cautionary Information Regarding Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which statements involve substantial risks and uncertainties. Forward-looking statements generally relate to future events or our future financial or operating performance. In some cases, you can identify forward-looking statements because they contain words such as “may,” “will,” “should,” “expect,” “plan,” “anticipate,” “could,” “would,” “intend,” “target,” “project,” “contemplate,” “believe,” “estimate,” “predict,” “potential” or “continue” or the negative of these words or other similar terms or expressions that concern our expectations, strategy, plans or intentions. Forward-looking statements in this press release include, but are not limited to, our beliefs regarding our financial position and operating performance, including our outlook and guidance for the first quarter and full year 2022, certain expected synergies from recent acquisitions and demand for our marketplace in general. Our expectations and beliefs regarding these matters may not materialize, and actual results in future periods are subject to risks and uncertainties that could cause actual results to differ materially from those projected, including risks and uncertainties related to: competition, managing our growth, financial performance, including the impact of the COVID-19 pandemic on our business and operations and our ability to forecast our performance due to our limited operating history and the COVID-19 pandemic, investments in new products or offerings, our ability to attract buyers and sellers to our marketplace, legal proceedings and regulatory matters and developments, any future changes to our business or our financial or operating model, and our brand and reputation. The forward-looking statements contained in this press release are also subject to other risks and uncertainties that could cause actual results to differ from the results predicted, including those more fully described in our filings with the SEC, including our Annual Report on Form 10-K for the period ended December 31, 2021. All forward-looking statements in this press release are based on information available to Xometry and assumptions and beliefs as of the date hereof, and we disclaim any obligation to update any forward-looking statements, except as required by law.

(Tables Follow)

  
Investor Contact: Media Contact:

Shawn Milne
VP Investor Relations
240-335-8132
shawn.milne@xometry.com
Matthew Hutchison
Corporate Communications for Xometry
415-583-2119
matthew.hutchison@xometry.com
  


Xometry, Inc. and Subsidiaries
Consolidated Balance Sheets
(In thousands, except share and per share data)

  December 31, 
  2021  2020 
  (unaudited)    
Assets      
Current assets:      
Cash and cash equivalents $86,262  $59,874 
Marketable securities  30,465    
Accounts receivable, less allowance for doubtful accounts of $0.8 million and $0.6 million as of December 31, 2021 and 2020, respectively  32,427   14,574 
Inventory  2,033   2,294 
Prepaid expenses  6,664   913 
Deferred sales commissions  5,283    
Other current assets  297    
Total current assets  163,431   77,655 
Property and equipment, net  10,287   6,113 
Operating lease right-of-use assets  27,489   1,922 
Investment in unconsolidated joint venture  4,198    
Intangible assets, net  41,736   1,652 
Goodwill  254,672   833 
Other assets  773   788 
Total assets $502,586  $88,963 
Liabilities, convertible preferred stock and stockholders’ equity      
Current liabilities:      
Accounts payable $12,718  $5,640 
Accrued expenses  30,905   13,606 
Contract liabilities  7,863   2,355 
Operating lease liabilities, current portion  5,549   1,013 
Finance lease liabilities, current portion  2   14 
Short-term debt     15,753 
Total current liabilities  57,037   38,381 
Operating lease liabilities, net of current portion  16,920   1,118 
Income taxes payable  1,468    
Other liabilities  1,678    
Total liabilities  77,103   39,499 
Commitments and contingencies (Note 12)      
Convertible preferred stock      
Convertible preferred stock, $0.000001 par value, Seed-1, Seed-2, Series A-1, Series A-2, Series B, Series C, Series D and Series E. Authorized; zero shares and 27,970,966 shares, zero shares and 27,758,941 shares issued and outstanding as of December 31, 2021 and 2020, respectively     160,713 
Stockholders’ equity (deficit)      
Preferred stock, $0.000001 par value. Authorized; 50,000,000 shares and zero shares; zero shares issued and outstanding as of December 31, 2021 and 2020, respectively      
Common stock, $0.000001 par value. Authorized; zero shares and 42,000,000 shares; zero shares and 7,755,782 shares issued and outstanding as of December 31, 2021 and 2020, respectively      
Class A Common stock, $0.000001 par value. Authorized; 750,000,000 shares and zero shares
43,998,404 shares and zero shares issued and outstanding as of December 31, 2021 and 2020, respectively
      
Class B Common stock, $0.000001 par value. Authorized; 5,000,000 shares and zero shares, 2,676,154 shares and zero shares issued and outstanding as of December 31, 2021 and 2020, respectively      
Additional paid-in capital  597,641   503 
Accumulated other comprehensive income  149   210 
Accumulated deficit  (173,341)  (111,962)
Total stockholders’ equity (deficit)  424,449   (111,249)
Noncontrolling interest  1,034    
Total equity (deficit)  425,483   (111,249)
Total liabilities, convertible preferred stock and stockholders’ equity $502,586  $88,963 


Xometry, Inc. and Subsidiaries
Consolidated Statements of Operations and Comprehensive Loss
(In thousands, except share and per share amounts)

  Three Months Ended
December 31,
  Year Ended
December 31,
 
  2021  2020  2021  2020 
  (unaudited)  (unaudited)    
Revenue $67,098  $37,980  $218,336  $141,406 
Cost of revenue  46,161   28,501   161,195   108,120 
Gross profit  20,937   9,479   57,141   33,286 
Sales and marketing  13,173   6,725   39,422   22,567 
Operations and support  8,089   3,973   23,683   14,111 
Product development  5,648   3,307   17,780   12,186 
General and administrative  16,601   3,255   34,942   12,046 
Impairment of goodwill and intangible assets     1,592      1,592 
Total operating expenses  43,511   18,852   115,827   62,502 
Loss from operations  (22,574)  (9,373)  (58,686)  (29,216)
Other (expenses) income            
Interest expense  (53)  (365)  (852)  (1,089)
Interest and dividend income  525      982    
Other expenses  (1,846)  (440)  (2,866)  (780)
Income from unconsolidated joint venture  41      41    
Total other expenses  (1,333)  (805)  (2,695)  (1,869)
Net loss  (23,907)  (10,178)  (61,381)  (31,085)
Deemed dividend to preferred stockholders           (8,801)
Net loss attributable to noncontrolling interest  2      2    
Net loss attributable to common stockholders $(23,905) $(10,178) $(61,379) $(39,886)
Net loss per share, basic and diluted $(0.53) $(1.34) $(2.33) $(5.32)
Weighted-average number of shares outstanding used to compute
net loss per share, basic and diluted
  44,995,598   7,572,935   26,318,349   7,492,876 
             
             
Comprehensive loss:            
Foreign currency translation $(38) $  $(61) $210 
Total other comprehensive (loss) income  (38)     (61)  210 
Net loss  (23,907)  (10,178)  (61,381)  (31,085)
Comprehensive loss  (23,945)  (10,178)  (61,442)  (30,875)
Comprehensive loss attributable to noncontrolling interest            
Total comprehensive loss attributable to common stockholders $(23,945) $(10,178) $(61,442) $(30,875)


Xometry, Inc. and Subsidiaries
Consolidated Statements of Cash Flows
(In thousands)

  Year Ended December 31, 
  2021  2020  2019 
Cash flows from operating activities: (unaudited)       
Net loss $(61,381) $(31,085) $(30,994)
Adjustments to reconcile net loss to net cash used in operating activities:         
Depreciation and amortization  3,596   3,120   1,847 
Impairment of goodwill and intangible assets     1,592   1,719 
Reduction in carrying amount of right-of-use asset  1,056   1,045   647 
Stock based compensation  7,395   1,006   544 
Non-cash interest expense  111   320   259 
Loss on debt extinguishment  272       
Income from unconsolidated joint venture  (41)      
Donation of common stock  2,226       
Unrealized loss on marketable securities  2,002       
Inventory write off     (15)  (141)
Loss (gain) on sale of property and equipment  20      (128)
Accretion of discount on short-term investments        (37)
Deferred taxes benefit  (179)      
Changes in other assets and liabilities:         
Accounts receivable, net  (11,117)  (2,130)  (5,505)
Inventory  293   (956)  (555)
Prepaid expenses  (4,025)  (210)  (2)
Deferred commissions  147       
Other assets  317   (469)  (137)
Accounts payable  5,215   (2,350)  2,813 
Accrued expenses  (12,008)  8,569   2,562 
Contract liabilities  (1,625)  518   636 
Lease liabilities  (845)  (1,004)  (653)
Net cash used in operating activities  (68,571)  (22,049)  (27,125)
Cash flows from investing activities:         
Purchase of marketable securities  (267,467)      
Proceeds from sale of marketable securities  235,000       
Purchase of short-term investments     (17,711)  (28,850)
Proceeds from short-term investments     28,571   30,470 
Purchases of property and equipment  (6,262)  (4,190)  (2,693)
Proceeds from life insurance  627       
Proceeds from sale of property and equipment        155 
Cash paid for business combinations, net of cash acquired  (174,646)     (1,432)
Net cash (used in) provided by investing activities  (212,748)  6,670   (2,350)
Cash flows from financing activities:         
Proceeds from issuance of Series A-2, Series B, Series C, Series D and Series E convertible preferred stock, net of issuance costs     52,409   54,929 
Repurchase of Series A-2, Series B, Series C and Series D convertible preferred stock     (12,852)   
Deemed dividend to preferred stockholders     (8,801)   
Proceeds from initial public offering, net of underwriters' discount  325,263       
Payments in connection with initial public offering  (3,678)      
Proceeds from stock options exercised  2,291   518   450 
Proceeds from the exercise of warrants  40       
Proceeds from term loan     4,000    
Payment on line of credit, net        (500)
Repayment of term loan  (16,136)      
Proceeds from other borrowings     4,783    
Repayment of other borrowings     (4,783)   
Payments on finance lease obligations  (12)  (13)  (164)
Net cash provided by financing activities  307,768   35,261   54,715 
Effect of foreign currency translation on cash and cash equivalents  (61)  (130)   
Net increase in cash and cash equivalents  26,388   19,752   25,240 
Cash and cash equivalents at beginning of the year  59,874   40,122   14,882 
Cash and cash equivalents at end of the year $86,262  $59,874  $40,122 
Supplemental cash flow information:         
Cash paid for interest $907  $1,269  $1,111 
Non-cash investing activity:         
Non-cash consideration in connection with business combination $105,227  $  $2,743 


Xometry, Inc. and Subsidiaries
Unaudited Reconciliations of Non-GAAP Financial Measures
(In thousands)

  Three Months Ended December 31,  For the Year Ended December 31, 
  2021  2020  2021  2020 
Adjusted EBITDA:            
Net loss $(23,907) $(10,178) $(61,381) $(31,085)
Add (deduct):            
             
Interest expense, interest and dividend income and other expenses  1,374   805   2,736   1,869 
Depreciation and amortization(1)  1,292   864   3,596   3,120 
Charitable contribution of common stock  1,084      2,242    
Stock-based compensation(2)  2,648   327   7,395   1,006 
Transaction costs  5,696      5,696    
Income from unconsolidated joint venture  (41)     (41)   
Impairment of goodwill and intangible assets     1,592      1,592 
Adjusted EBITDA $(11,854) $(6,590) $(39,757) $(23,498)

(1)   Represents depreciation expense of the Company’s long-lived tangible assets and amortization expense of its finite-lived intangible assets, as included in the Company’s GAAP results of operations.
(2)   Represents the expense related to stock-based awards granted to employees, as included in the Company’s GAAP results of operations.


Xometry, Inc. and Subsidiaries
Segment Results
(In thousands)

  Three Months Ended
December 31,
  For the Year Ended
December 31,
 
  2021  2020  2021  2020 
Segment Revenue: (unaudited)  (unaudited)    
U.S. $61,769  $36,734  $202,034  $138,272 
International  5,329   1,246   16,302   3,134 
Total revenue $67,098  $37,980  $218,336  $141,406 
             
Segment Net Loss:            
U.S. $(21,080) $(6,040) $(51,230) $(22,130)
International  (2,827)  (4,138)  (10,151)  (8,955)
Total net loss $(23,907) $(10,178) $(61,381) $(31,085)

  

Xometry, Inc. and Subsidiaries
Supplemental Information
(In thousands)

  Three Months Ended
December 31,
  For the Year Ended
December 31,
 
  2021  2020  2021  2020 
Summary of Stock-based Compensation Expense (unaudited)  (unaudited)    
Sales and marketing $533  $51  $1,223  $156 
Operations and support  1,295   84   2,659   259 
Product development  765   122   1,744   375 
General and administrative  55   70   1,769   216 
Total stock-based compensation expense $2,648  $327  $7,395  $1,006 
             
Summary of Depreciation and Amortization Expense            
Cost of revenue $34  $52  $104  $230 
Sales and marketing  211   157   300   665 
Operations and support  36   52   155   196 
Product development  909   500   2,821   1,720 
General and administrative  102   103   216   309 
Total depreciation and amortization expense $1,292  $864  $3,596  $3,120 

For the three and twelve months ended December 31, 2021, general and administrative expense includes $1.1 million and $2.2 million, respectively of expense related to charitable contributions.


Primary Logo